The Shantou Ultrasound GEM IPO registration took effect as a leading enterprise in the domestic ultrasonic nondestructive testing industry

The Zhitong Finance App learned that on October 15, Sichuan 6912 Communication Technology Co., Ltd. (abbreviation: Shantou Ultrasound) Shenzhen Stock Exchange GEM IPO review status was changed to “registration effective”. Galaxy Securities is its sponsor and plans to raise 3114.6 million yuan.

According to the prospectus, Shantou Ultrasound is a national key high-tech enterprise mainly engaged in R&D, production and sales of medical imaging equipment and industrial nondestructive testing equipment. Compared with comparable listed companies in the same industry, the company is the only domestic enterprise that is also engaged in R&D, production and sales of medical ultrasound imaging equipment and industrial ultrasonic nondestructive testing equipment.

As a leading enterprise in the domestic ultrasonic nondestructive testing industry, the company has successively presided over the preparation of national or industry standards for analog instruments, digital instruments and imaging instruments, and established and standardized performance testing and acceptance methods for industry products.

On the financial side, in 2021, 2022, 2023, and January-June 2024, Shantou Ultrasound achieved operating income of 284 million yuan, 336 million yuan, 327 million yuan, and 160 million yuan; during the same period, the company achieved net profit of 759.208 million yuan, 127 million yuan, 115 million yuan, and 577.618 million yuan.